SCHEMBL29200748

SCHEMBL29200748

COc1ccc(CN(Cc2ccc(OC)cc2)c2cc3ccccc3c(O)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
LMNA P02545 2/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
CYP2D6 P10635 1/20 0.44
DRD1 P21728 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30803652 1.00 MEN1 (0.49) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL21733480 0.84 MEN1 (0.44) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL29999713 0.84 MEN1 (0.44) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL29200689 0.84 PTGDR2 (0.40) MEN1KMT2ALMNATSHRALDH1A1
SCHEMBL29937019 0.84 PTGDR2 (0.40) MEN1KMT2ALMNATSHRALDH1A1
SCHEMBL30803568 0.80 MEN1 (0.41) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL28903971 0.78 NPC1 (0.51) MEN1KMT2ALMNATSHRALDH1A1
SCHEMBL13728488 0.75 ERAP1 (0.51) MEN1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL21733481 0.74 ALDH1A1 (0.36) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL22775885 0.72 PTK2 (0.58) MEN1KMT2ALMNATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659050-A Quinazoline heterocyclic derivatives as KRAS mutation inhibitors for the treatment of cancer 深圳福沃药业有限公司 2024-03-08 CN disclosed